Monographie - Alprostadil

zadnja posodobitev :
11/12/2024

Alprostadil

Kemična formula

Lastniško ime

Sestava pomožnih snovi je med paralelami lahko različna

Alfaprostin	Egipt
Alistint	Peru
Alpros	Turčija
Alprostadil	Argentina, Čile, Ekvador, Kanada, Malezija, Nemčija, Peru, Romunija, Španija, Turčija, Združene države Amerike
Alprostapint	Argentina, Avstrija, Ekvador, Kolumbija, Madžarska, Peru
Alprostar	Italija
Aplicav	Brazilija
Cardiobon	Argentina, Peru
Caverject	Avstrija, Belgija, Brazilija, Danska, Francija, Italija, Južnoafriška republika, Kanada, Norveška, Poljska, Portugalska, Slovenija, Španija, Švedska, Švica, Turčija, Velika Britanija, Združene države Amerike
Edex	Francija
Liple	Japonska
Minprog	Avstrija, Nemčija
Ostapint	Mehika, Peru
Palux	Japonska
Pridax	Avstrija, Nemčija, Romunija, Španija
Prolisina VR	Argentina
Prostandin	Japonska
Prostavasin	Avstrija, Egipt, Iran, Italija, Luksemburg, Madžarska, Nemčija, Poljska
Prostin VR	Avstralija, Belgija, Danska, Finska, Grčija, Iran, Italija, Kanada, Luksemburg, Madžarska, Malezija, Nizozemska, Norveška, Poljska, Portugalska, Savdska Arabija, Švica, Velika Britanija, Venezuela, Združene države Amerike
Prostine VR	Francija
Vasaprostan	Romunija

Viri : Alprostadil

	Tip	objava
1072	časopis	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899	časopis	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003	časopis	Paul M, Razzouq N, Tixier G, Astier A. Stability of prostaglandin E1 (PGE1) in aqueous solutions. EJHP Science 2005 ; 2: 31-36.
2090	časopis	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2150	časopis	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
2151	časopis	Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int J Pharm 1995 ; 115: 113-117.
3201	časopis	Dice JE. Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448	časopis	Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761	Knjiga	Chavan E. Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Master en pharmacie - University of Geneva 2014
3961	časopis	McCluskey S.V,Kirkham K,Munson J.M. Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069	časopis	Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. EJHP 2018 ; 25, e2
4389	časopis	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4491	časopis	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2020
4507	časopis	Ross E, Salinas A, Petty K, Her C, Carpenter J. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543	časopis	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4570	časopis	Greenhill K, Hornsby E, Gorman G. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 2019
4651	časopis	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2021 ;180,1169–1176.
4837	časopis	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales